CRISPR studies identify genes preferentially essential for myeloma cells vs. other neoplasias: implications for future therapies selective against MM

Ryosuke Shirasaki, Ricardo de Matos Simoes, Sondra Downey-Kopyscinski, Geoffrey Matthews, Yiguo Hu, Michal Sheffer, Eugen Dhimolea, Olga Dashevsky, Sara Gandolfi, Paul Hengeveld, Joshua Dempster, Robin Meyers, Jordan Bryan, Neekesh Dharia, James McFarland, Subhashis Sarkar, Johanna Bruggenthies, Huihui Tang, Megan Bariteau, Andrew AguirreMinasri Borah, Quinlan Sievers, Benjamin Ebert, Joseline Raja, Brian J. Glassner, Christopher Ott, James Bradner, Nicholas Kwiatkowski, Daniel Auclair, Joan Levy, Haley Poarch, Tinghu Zhang, Jacob Laubach, Dennis Buckley, Robert Schlossman, Richard Groen, Eric Fischer, Paul G. Richardson, Jonathan Keats, Lawrence Boise, Jonathan Licht, Aedin Culhane, Nathanael Gray, William Hahn, Francisca Vazquez, Aviad Tsherniak, Constantine Mitsiades

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)E48-E49
JournalClinical Lymphoma Myeloma and Leukemia
Volume19
Issue number10
Publication statusPublished - Oct 2019

Cite this